BIND Therapeutics To Present At Wedbush 2014 Life Sciences Management Access Conference

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the Wedbush 2014 Life Sciences Management Access Conference in New York on Wednesday, August 13, 2014 at 10:55 a.m. ET.

Help employers find you! Check out all the jobs and post your resume.